Wistar Institute, University of the Sciences Partner in Philly Molecular Screening Facility | GenomeWeb
NEW YORK (GenomeWeb News) — The Wistar Institute and the University of the Sciences, both located in Philadelphia, today unveiled a new Molecular Screening Facility at the institute, which is part of a larger medical research partnership between them that will seek new compounds for potential therapies.
 
The $1.1 million screening facility and the Center for Chemical Biology and Translational Medicine combines Wistar’s biomedical research capabilities with the University of Sciences’ chemical and pharmacological expertise.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.